Revision history of "Gefitinib for oesophageal cancer progressing after chemotherapy (COG): a phase 3, multicentre, double-blind, placebo-controlled randomised trial." (Q39172509)

Jump to navigation Jump to search

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

28 June 2021

26 June 2021

9 May 2021

7 August 2020

24 June 2020

21 March 2020

13 June 2019

14 December 2018

13 January 2018

8 November 2017

10 September 2017

9 September 2017